A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients | Zendy

Luk Rombauts | Zendy; David Healy | Zendy; Robert J. Norman | Zendy

Open Access

A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients

Author(s) -

Luk Rombauts,

David Healy,

Robert J. Norman

Publication year - 2005

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dei302

Subject(s) - hormone antagonist , follicular phase , medicine , gonadotropin releasing hormone antagonist , antagonist , randomized controlled trial , hormone , gynecology , gonadotropin releasing hormone , endocrinology , physiology , luteinizing hormone , receptor

This randomized controlled trial was designed to assess the impact of oral contraceptive (OC) scheduling with a GnRH antagonist (ganirelix) regimen on the ovarian response of women undergoing recombinant FSH (rFSH) stimulation for IVF, compared with a non-scheduled ganirelix regimen and a long GnRH agonist (nafarelin) protocol.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research